COVID-19 has turned investors’ attention to healthcare stocks, many of which have reached record highs of late. While these types of stocks provide essential goods and services to the population, Bob Desmond, Head of International Equities at Evans and Partners, says this isn’t a sector he’s particularly keen on – a legacy of the fund manager’s philosophy of finding companies where you don’t need to predict anything. “And a lot of healthcare involves prediction,” he says.
Still, Bob does reveal a healthcare stock that is on his watchlist – the animal health company Zoetis, which was spun out of Pfzier – and discusses why he likes it, although not at the current price.
Evans and Partners International Fund is a high conviction portfolio of value-creating businesses at reasonable prices. They consider ourselves true stock-pickers and look to avoid owning businesses that depend on a benign or favourable economic environment. To learn more, use the contact button below.